Top Markets
#1 Official Trump Official Trump +53.72%
#2 Melania Meme Melania Meme +46.36%
#3 Mubarak Mubarak +41.69%
#4 The Bitcoin Bull The Bitcoin Bull +29.56%
#5 The Black Bull The Black Bull +20.29%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +20.00%
#7 VVS Finance VVS Finance +19.70%
#8 Movement Movement +19.64%
#9 Cronos Cronos +19.58%
#10 EXOD EXOD +18.93%
Coin of the day
Official Trump Official Trump
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Immuno-Biological Laboratories Co., Ltd. Immuno-Biological Laboratories Co., Ltd.

Immuno-Biological Laboratories Co., Ltd.

4570
Classifica tra le azioni #24051
Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to... Immuno-Biological Laboratories Co., Ltd. (IBL) is a global entity dedicated to the research, development, production, and distribution of immunological reagents. The company's diverse offerings include ELISA assay kits designed for the precise quantitative measurement of targeted substances, alongside comprehensive research support services focusing on areas such as Alzheimer's disease, metabolic syndrome, and cancer. IBL also caters to specific client needs through customized services for antibody production and the development of bespoke ELISA systems. A prominent service is LipoSEARCH, which provides tailored lipoprotein profiling and analysis utilizing gel-filtration high-performance liquid chromatography. This advanced method allows for the in-depth examination of even minute plasma or serum samples from both humans and small animals, supporting a broad spectrum of research, including lipid metabolism, the creation of pharmaceuticals for lifestyle-related diseases, functional food development, and clinical investigations. For animal health, IBL offers LipoTEST, a diagnostic and health screening tool for veterinary clinics, complemented by personalized biomarker testing services for lifestyle-related conditions. Furthermore, the company operates an innovative protein production division that leverages transgenic silkworms. This technology is instrumental in manufacturing antibodies for research and diagnostic applications, human collagen for cosmetic use, proteins for drug development, and other specialized proteins. Established in 1982, Immuno-Biological Laboratories Co., Ltd. is headquartered in Fujioka, Japan.
Prezzo delle azioni
$7.05
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$65.63M
Variazione (1 giorno)
-1.64%
Variazione (1 anno)
117.11%
Paese
JP
Scambia Immuno-Biological Laboratories Co., Ltd. (4570)

Categoria

Healthcare
Ricavi di Immuno-Biological Laboratories Co., Ltd. (4570)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Immuno-Biological Laboratories Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Immuno-Biological Laboratories Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH